Advertisement
Advertisement
September 20, 2024
Stryker Acquires Nico Corporation
September 20, 2024—Stryker announced that it has completed the acquisition of Nico Corporation, a privately held company providing a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures.
According to Stryker, the acquisition further strengthens its commitment to neurotechnology through tumor and stroke care. The company stated that Nico’s BrainPath and Myriad products enable a treatment option for ICH with improved functional outcomes compared to guideline-based medical management alone, the current standard of care.
“The acquisition of Nico Corporation expands Stryker’s portfolio of solutions for tumor resection and the treatment of ICH, the deadliest form of stroke,” stated Andy Pierce, Group President of MedSurg and Neurotechnology at Stryker, in the press release. “As a global leader in neurosurgical access and removal tools, this strategic addition enables us to deliver differentiated, minimally invasive approaches that will drive meaningful outcomes and improve the lives of patients worldwide.”
Advertisement
Advertisement
